Valeant Pharmaceuticals to Announce 2011 Fourth Quarter and Full Year Results on February 27, 2012

February 08, 2012

MISSISSAUGA, Ontario, Feb. 8, 2012 /PRNewswire/ -- Valeant Pharmaceuticals International, Inc. (NYSE: VRX) (TSX: VRX) today announced that it will host a conference call and a live Internet webcast along with a slide presentation on Monday, February 27, 2012 at 10:00 a.m. ET (7:00 a.m. PT) to discuss results for the 2011 fourth quarter and full year.

The dial-in number to participate on this call is (877) 876-8393, confirmation code 49361027.  International callers should dial (973) 200-3961, confirmation code 49361027. A replay will be available approximately two hours following the conclusion of the conference call to Monday, March 5, 2012, and can be accessed by dialing (855) 859-2056 or (404) 537-3406, confirmation code 49361027.

The webcast and slide presentation will be hosted in the investor relations section of its corporate Web site at www.valeant.com. Participants should allow approximately five to 10 minutes prior to the call's start time to visit the site and to download any streaming media software needed to listen to the Internet webcast. An online archive of the webcast will be available following the end of the live call in the webcast archive portion of the investor relations section at www.valeant.com.

About Valeant

Valeant Pharmaceuticals International, Inc. (NYSE/TSX: VRX) is a multinational specialty pharmaceutical company that develops, manufactures and markets a broad range of pharmaceutical products primarily in the areas of neurology, dermatology and branded generics.  More information about Valeant can be found at www.valeant.com.

(Logo: http://photos.prnewswire.com/prnh/20101025/LA87217LOGO)

Contact Information:
Laurie W. Little 
949-461-6002 
laurie.little@valeant.com